Sign In
Buy CANF
$3.06
+0.0800 (+2.68%)
At Close: Jun 22, 2026
Can-Fite BioPharma Earnings Calls
Mar 31, 2026
| Release date | Apr 13, 2026 |
| EPS estimate | -$27.00 |
| EPS actual | - |
| Revenue estimate | 300K |
| Revenue actual | - |
Dec 31, 2025
-$5.97 (77.89%)
| Release date | Mar 26, 2026 |
| EPS estimate | -$27.00 |
| EPS actual | -$5.97 |
| EPS Surprise | 77.89% |
| Revenue estimate | 300K |
| Revenue actual | 203K |
| Revenue Surprise | -32.33% |
Jun 30, 2025
| Release date | Aug 28, 2025 |
| EPS estimate | - |
| EPS actual | -$0.214 |
| Revenue estimate | - |
| Revenue actual | 101K |
Mar 31, 2025
-$0.214 (10.68%)
| Release date | Apr 14, 2025 |
| EPS estimate | -$0.240 |
| EPS actual | -$0.214 |
| EPS Surprise | 10.68% |
| Revenue estimate | - |
| Revenue actual | 101K |
Last 4 Quarters for Can-Fite BioPharma
Below you can see how CANF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Mar 31, 2025
Beat
| Release date | Apr 14, 2025 |
| Price on release | $26.00 |
| EPS estimate | -$0.240 |
| EPS actual | -$0.214 |
| EPS surprise | 10.68% |
| Date | Price |
|---|---|
| Apr 08, 2025 | $26.60 |
| Apr 09, 2025 | $28.20 |
| Apr 10, 2025 | $27.96 |
| Apr 11, 2025 | $31.40 |
| Apr 14, 2025 | $26.00 |
| Apr 15, 2025 | $25.20 |
| Apr 16, 2025 | $24.60 |
| Apr 17, 2025 | $24.00 |
| Apr 21, 2025 | $24.80 |
| 4 days before | -2.26% |
| 4 days after | -4.62% |
| On release day | -3.08% |
| Change in period | -6.77% |
Jun 30, 2025
| Release date | Aug 28, 2025 |
| Price on release | $13.27 |
| EPS estimate | - |
| EPS actual | -$0.214 |
| Date | Price |
|---|---|
| Aug 22, 2025 | $13.22 |
| Aug 25, 2025 | $13.04 |
| Aug 26, 2025 | $13.10 |
| Aug 27, 2025 | $13.25 |
| Aug 28, 2025 | $13.27 |
| Aug 29, 2025 | $12.63 |
| Sep 02, 2025 | $13.24 |
| Sep 03, 2025 | $13.24 |
| Sep 04, 2025 | $13.03 |
| 4 days before | 0.378% |
| 4 days after | -1.78% |
| On release day | -4.84% |
| Change in period | -1.41% |
Dec 31, 2025
Beat
| Release date | Mar 26, 2026 |
| Price on release | $3.29 |
| EPS estimate | -$27.00 |
| EPS actual | -$5.97 |
| EPS surprise | 77.89% |
| Date | Price |
|---|---|
| Mar 20, 2026 | $3.17 |
| Mar 23, 2026 | $3.24 |
| Mar 24, 2026 | $3.13 |
| Mar 25, 2026 | $3.23 |
| Mar 26, 2026 | $3.29 |
| Mar 27, 2026 | $3.14 |
| Mar 30, 2026 | $3.01 |
| Mar 31, 2026 | $3.10 |
| Apr 01, 2026 | $3.09 |
| 4 days before | 3.79% |
| 4 days after | -6.08% |
| On release day | -4.56% |
| Change in period | -2.52% |
Mar 31, 2026
| Release date | Apr 13, 2026 |
| Price on release | $2.92 |
| EPS estimate | -$27.00 |
| EPS actual | - |
| Date | Price |
|---|---|
| Apr 07, 2026 | $3.03 |
| Apr 08, 2026 | $3.08 |
| Apr 09, 2026 | $2.93 |
| Apr 10, 2026 | $2.92 |
| Apr 13, 2026 | $2.92 |
| Apr 14, 2026 | $3.05 |
| Apr 15, 2026 | $3.17 |
| Apr 16, 2026 | $3.08 |
| Apr 17, 2026 | $3.04 |
| 4 days before | -3.63% |
| 4 days after | 4.11% |
| On release day | 4.45% |
| Change in period | 0.330% |
Can-Fite BioPharma Earnings History
Earnings Calendar
FAQ
When is the earnings report for CANF?
Can-Fite BioPharma Ltd (CANF) has scheduled its earnings report for Aug 27, 2026 after the markets close.
What is the CANF price-to-earnings (P/E) ratio?
CANF P/E ratio as of Jun 22, 2026 (TTM) is -695.47.
What is the CANF EPS forecast?
The forecasted EPS (Earnings Per Share) for Can-Fite BioPharma Ltd (CANF) for the first fiscal quarter 2026 is -$0.508.
What are Can-Fite BioPharma Ltd's retained earnings?
On its balance sheet, Can-Fite BioPharma Ltd reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
